JSR

JSR Corporation, founded in 1957 and headquartered in Tokyo, Japan, operates primarily in the petrochemical and fine chemicals sectors. The company has four main segments: elastomers, plastics, digital solutions, and life sciences. Its elastomers segment produces synthetic rubbers, thermoplastic elastomers, and emulsions, generating the highest revenue. The plastics segment includes various synthetic resins such as ABS and AES. Digital solutions encompass semiconductor materials, display materials, and edge computing technologies, while the life sciences division focuses on research and diagnostic reagents, bioprocess materials, and medical polymers. JSR's global operations extend across Japan, South Korea, China, Taiwan, Thailand, the United States, and Belgium, where it also develops advanced materials for electronics, including lithography and packaging materials.

Mitsunobu Koshiba

President

22 past transactions

Fluence Analytics

Venture Round in 2021
Fluence Analytics, Inc. specializes in manufacturing monitoring solutions for industrial and laboratory settings, focusing on the measurement and analysis of polymer production processes. The company provides a system that analyzes polymers during production and a light scattering instrument designed to assess the stability of therapeutic proteins and the quality of both natural and synthetic polymers. By generating continuous data streams and employing proprietary analytical tools, Fluence Analytics enables real-time optimization of process control and accelerates research and development for its clients in the polymer and biopharmaceutical sectors. Founded in 2012 and based in New Orleans, Louisiana, the company was previously known as Advanced Polymer Monitoring Technologies, Inc. before rebranding in April 2017.

Vedanta Biosciences

Series D in 2021
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Iridia

Series B in 2021
Iridia, Inc. is a nanotechnology company based in Carlsbad, California, focused on developing innovative DNA-based data storage solutions. Founded in 2016, Iridia combines expertise in biochemistry, molecular biology, and semiconductor fabrication to create a groundbreaking read and write data storage hard drive that utilizes DNA for long-term data retention. By leveraging DNA polymer synthesis technology and electronic nano-switches, the company aims to achieve exceptionally high-density data storage through a highly-parallel format that includes an array of nanomodules. Formerly known as Dodo OmniData, Inc., Iridia rebranded in March 2018 to reflect its commitment to advancing data storage technology.

AlphaICs

Series B in 2021
AlphaICs India Private Limited specializes in developing artificial intelligence system on a chip (SoC) solutions, offering purpose-built SoCs and FPGA boards alongside deep learning chips for various client-side applications. Founded in 2016 and headquartered in Bengaluru, India, the company targets a wide range of industries, including home automation, healthcare wearables, drones, agriculture, robotics, and surveillance systems. AlphaICs is known for its patented technology, Real AI Processing (RAP), which aims to enhance AI computing capabilities in areas such as self-driving cars, robotics, and intelligent cloud computing. With a focus on advancing AI compute, AlphaICs is positioned to play a significant role in the development of autonomous systems.

Cambridge Quantum Computing

Venture Round in 2020
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company specializes in developing tools for the commercialization of quantum computers by understanding quantum protocols and algorithms. Its key offerings include t|ket, a quantum development platform; EUMEN, an enterprise application focused on quantum chemistry; QML, which pertains to quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum technology. As quantum devices become more prevalent, the company concentrates on advancing algorithms and source code to drive innovation in this emerging field.

Inpria

Series C in 2020
Inpria Corporation, founded in 2007 and based in Corvallis, Oregon, specializes in the design, development, and manufacture of EUV metal oxide photoresists. The company is recognized as a pioneer in extending semiconductor lithography by utilizing inorganic photoresists and thin films for nanoscale patterning. Inpria’s innovative photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from a solution, which can be photopatterned. This technology enhances performance while simplifying processing, supporting advancements in EUV lithography and addressing the growing demands of the semiconductor industry.

Carbon

Series E in 2019
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

Carbon

Series E in 2019
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

Cambridge Quantum Computing

Funding Round in 2019
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company specializes in developing tools for the commercialization of quantum computers by understanding quantum protocols and algorithms. Its key offerings include t|ket, a quantum development platform; EUMEN, an enterprise application focused on quantum chemistry; QML, which pertains to quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum technology. As quantum devices become more prevalent, the company concentrates on advancing algorithms and source code to drive innovation in this emerging field.

Mattrix Technologies

Series A in 2019
Mattrix Technologies Inc., founded in 2018 and based in Gainesville, Florida, specializes in the development and manufacturing of full-aperture organic light emitting transistor (OLET) displays. These displays represent a new approach to emissive technology, addressing the limitations associated with traditional OLED backplanes that have hindered broader adoption of OLED displays. Through its innovative solutions, Mattrix Technologies aims to enhance display performance and usability in various applications.

Vedanta Biosciences

Series C in 2019
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

FLOSFIA

Corporate Round in 2019
FLOSFIA INC. is a Tokyo-based company that specializes in the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the firm emerged as a spin-off from research conducted at Kyoto University. FLOSFIA focuses on utilizing the unique physical properties of gallium oxide to create low-loss power devices that offer high breakdown voltage and efficiency. The company employs mist chemical vapor deposition (CVD) techniques for film formation, which enhances the performance of its semiconductor products.

Absci

Series D in 2019
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

Cambridge Quantum Computing

Funding Round in 2018
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company specializes in developing tools for the commercialization of quantum computers by understanding quantum protocols and algorithms. Its key offerings include t|ket, a quantum development platform; EUMEN, an enterprise application focused on quantum chemistry; QML, which pertains to quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum technology. As quantum devices become more prevalent, the company concentrates on advancing algorithms and source code to drive innovation in this emerging field.

Carbon

Series D in 2017
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

Thermalin

Series A in 2017
Thermalin Diabetes, LLC is a biotechnology company based in Cleveland, Ohio, with an additional office in Newton, Massachusetts. Founded in 2010, the company specializes in developing insulin analogs for the treatment of Type 1 and Type 2 diabetes. Its product offerings include ultra-rapid acting insulin designed to be administered before meals to mitigate glucose spikes, as well as long-acting insulin to maintain basal glucose levels. Thermalin aims to innovate within the insulin market by introducing a highly concentrated, stabilized ultra-rapid acting insulin that can be used in a disposable glucose management system. This new insulin formulation also facilitates the factory-filling of reservoirs for existing insulin pumps. Additionally, the company is exploring partnerships to develop no-cold-chain basal and mixed insulins, as well as glucose-responsive insulins, to enhance patient compliance and treatment outcomes.

LEXI Japan

Acquisition in 2017
LEXI Co., Ltd., based in Tokyo, Japan, specializes in developing medical software and hardware focused on scientific visualization and simulation. Founded in 1988, the company provides advanced 3D pre-operative planning orthopedic software designed for total and partial hip and knee arthroplasty, as well as osteotomy procedures. This software, which is CE-marked and FDA-cleared, is utilized in over 250 medical institutions across Japan. By facilitating detailed surgical planning in a 3D environment, LEXI's solutions enhance the performance of surgeons and improve the quality of life for patients. The company operates under a quality management system certified to ISO 13485 standards and is a subsidiary of JSR Corporation since 2017.

Inpria

Series B in 2017
Inpria Corporation, founded in 2007 and based in Corvallis, Oregon, specializes in the design, development, and manufacture of EUV metal oxide photoresists. The company is recognized as a pioneer in extending semiconductor lithography by utilizing inorganic photoresists and thin films for nanoscale patterning. Inpria’s innovative photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from a solution, which can be photopatterned. This technology enhances performance while simplifying processing, supporting advancements in EUV lithography and addressing the growing demands of the semiconductor industry.

Light Polymers

Series B in 2017
Light Polymers Inc. is a materials company specializing in the synthesis and development of self-aligning lyotropic liquid crystal solutions. Founded in 2006 and headquartered in South San Francisco, California, with additional facilities in Silicon Valley and Taiwan, the company focuses on applications in flat panel displays, LED lighting, smart glass, solar technologies, and horticultural lighting. Its innovative materials address significant challenges in the flat panel display industry, particularly in the production of optical film polarizers, which traditionally require complex and costly processes. Light Polymers' products enable the creation of thin, coatable polarizers that enhance brightness and efficiency for ultra-high-definition displays, while also aligning with market trends in flexible and transparent technologies. The company’s solutions cater to various sectors, offering customers advanced materials for optical films, specialty plastics, and manufacturing processes.

Selexis

Acquisition in 2017
Selexis SA is a life sciences company based in Plan-les-Ouates, Switzerland, specializing in mammalian cell-line generation technologies to support the development of new therapies. Founded in 2001, Selexis offers the Selexis SUREtechnology Platform, which aids in the discovery, development, and production of recombinant proteins. Its services encompass cell-line development, lead identification, genomic characterization, and applications in bioproduction, preclinical production, target discovery, cell-based assays, and diagnostics. Serving biotechnology and pharmaceutical companies on a global scale, Selexis plays a crucial role in translating scientific innovations into effective medicines for patients. As of June 2017, the company operates as a subsidiary of KBI Biopharma Inc.

Carbon

Series C in 2016
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

Lehigh Technologies

Venture Round in 2014
Lehigh Technologies is a specialty materials company that transforms end-of-life tires and other post-industrial rubber into high-performance, lower cost, sustainable micronized rubber powders (MRP). These MRPs replace oil- and rubber-based feedstocks in a wide range of industrial and consumer applications, including high performance tires, consumer and industrial plastics, consumer goods, coatings & sealants and construction materials. Lehigh tailors its PolyDyne™ and MicroDyne™ MRPs to customers’ needs to maximize benefits and optimize performance. Lehigh also offers its customers comprehensive Closed-Loop services. Lehigh Technologies operates the world’s largest MRP manufacturing plant just outside of Atlanta, with an annual production capacity of 140 million pounds. Lehigh also has the world’s leading MRP research and development facility, its Application & Development Center.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.